Evaluation of a web-based cognitive rehabilitation program in cancer survivors reporting cognitive symptoms after chemotherapy

Victoria J. Bray, Haryana M. Dhillon, Melanie L Bell, Michael Kabourakis, Mallorie H. Fiero, Desmond Yip, Frances Boyle, Melanie A. Price, Janette L. Vardy

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Purpose Cognitive impairment is reported frequently by cancer survivors. There are no proven treatments. We evaluated a cognitive rehabilitation program (Insight) and compared it with standard care in cancer survivors self-reporting cognitive symptoms. Patients and Methods We recruited adult cancer survivors with a primary malignancy (excluding central nervous system malignancies) who had completed three or more cycles of adjuvant chemotherapy in the previous 6 to 60 months and reported persistent cognitive symptoms. All participants received a 30-minute telephone consultation and were then randomly assigned to the 15-week, home-based intervention or to standard care. Primary outcome was self-reported cognitive function (Functional Assessment of Cancer Therapy Cognitive Function [FACT-COG] perceived cognitive impairment [PCI] subscale): difference between groups after intervention (T2) and 6 months later (T3). Results A total of 242 participants were randomly assigned: median age, 53 years; 95% female. The primary outcome of difference in FACT-COG PCI was significant, with less PCI in the intervention group at T2 (P<.001). This difference was sustained at T3 (P<.001). At T2, there was a significant difference in all FACT-COG subscales, favoring the intervention. Neuropsychological results were not significantly different between the groups at T2 or T3. There were significantly lower levels of anxiety/depression and fatigue in the intervention group at T2. There were significant improvements in stress in the intervention group at both time points. There was no significant difference in quality of life between the groups at T2, but the intervention group had better quality of life at T3. Conclusion The intervention, Insight, led to improvements in cognitive symptoms compared with standard care. To our knowledge, this is the first large randomized controlled trial showing an improvement in selfreported cognitive function in cancer survivors, indicating that this intervention is a feasible treatment.

Original languageEnglish (US)
Pages (from-to)217-225
Number of pages9
JournalJournal of Clinical Oncology
Volume35
Issue number2
DOIs
StatePublished - Jan 10 2017

Fingerprint

Neurobehavioral Manifestations
Survivors
Rehabilitation
Drug Therapy
Cognition
Neoplasms
Quality of Life
Therapeutics
Adjuvant Chemotherapy
Telephone
Fatigue
Referral and Consultation
Anxiety
Central Nervous System
Randomized Controlled Trials
Depression
Cognitive Dysfunction

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Evaluation of a web-based cognitive rehabilitation program in cancer survivors reporting cognitive symptoms after chemotherapy. / Bray, Victoria J.; Dhillon, Haryana M.; Bell, Melanie L; Kabourakis, Michael; Fiero, Mallorie H.; Yip, Desmond; Boyle, Frances; Price, Melanie A.; Vardy, Janette L.

In: Journal of Clinical Oncology, Vol. 35, No. 2, 10.01.2017, p. 217-225.

Research output: Contribution to journalArticle

Bray, Victoria J. ; Dhillon, Haryana M. ; Bell, Melanie L ; Kabourakis, Michael ; Fiero, Mallorie H. ; Yip, Desmond ; Boyle, Frances ; Price, Melanie A. ; Vardy, Janette L. / Evaluation of a web-based cognitive rehabilitation program in cancer survivors reporting cognitive symptoms after chemotherapy. In: Journal of Clinical Oncology. 2017 ; Vol. 35, No. 2. pp. 217-225.
@article{cf29f2e32bac4b8984c2e7a23780cced,
title = "Evaluation of a web-based cognitive rehabilitation program in cancer survivors reporting cognitive symptoms after chemotherapy",
abstract = "Purpose Cognitive impairment is reported frequently by cancer survivors. There are no proven treatments. We evaluated a cognitive rehabilitation program (Insight) and compared it with standard care in cancer survivors self-reporting cognitive symptoms. Patients and Methods We recruited adult cancer survivors with a primary malignancy (excluding central nervous system malignancies) who had completed three or more cycles of adjuvant chemotherapy in the previous 6 to 60 months and reported persistent cognitive symptoms. All participants received a 30-minute telephone consultation and were then randomly assigned to the 15-week, home-based intervention or to standard care. Primary outcome was self-reported cognitive function (Functional Assessment of Cancer Therapy Cognitive Function [FACT-COG] perceived cognitive impairment [PCI] subscale): difference between groups after intervention (T2) and 6 months later (T3). Results A total of 242 participants were randomly assigned: median age, 53 years; 95{\%} female. The primary outcome of difference in FACT-COG PCI was significant, with less PCI in the intervention group at T2 (P<.001). This difference was sustained at T3 (P<.001). At T2, there was a significant difference in all FACT-COG subscales, favoring the intervention. Neuropsychological results were not significantly different between the groups at T2 or T3. There were significantly lower levels of anxiety/depression and fatigue in the intervention group at T2. There were significant improvements in stress in the intervention group at both time points. There was no significant difference in quality of life between the groups at T2, but the intervention group had better quality of life at T3. Conclusion The intervention, Insight, led to improvements in cognitive symptoms compared with standard care. To our knowledge, this is the first large randomized controlled trial showing an improvement in selfreported cognitive function in cancer survivors, indicating that this intervention is a feasible treatment.",
author = "Bray, {Victoria J.} and Dhillon, {Haryana M.} and Bell, {Melanie L} and Michael Kabourakis and Fiero, {Mallorie H.} and Desmond Yip and Frances Boyle and Price, {Melanie A.} and Vardy, {Janette L.}",
year = "2017",
month = "1",
day = "10",
doi = "10.1200/JCO.2016.67.8201",
language = "English (US)",
volume = "35",
pages = "217--225",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "2",

}

TY - JOUR

T1 - Evaluation of a web-based cognitive rehabilitation program in cancer survivors reporting cognitive symptoms after chemotherapy

AU - Bray, Victoria J.

AU - Dhillon, Haryana M.

AU - Bell, Melanie L

AU - Kabourakis, Michael

AU - Fiero, Mallorie H.

AU - Yip, Desmond

AU - Boyle, Frances

AU - Price, Melanie A.

AU - Vardy, Janette L.

PY - 2017/1/10

Y1 - 2017/1/10

N2 - Purpose Cognitive impairment is reported frequently by cancer survivors. There are no proven treatments. We evaluated a cognitive rehabilitation program (Insight) and compared it with standard care in cancer survivors self-reporting cognitive symptoms. Patients and Methods We recruited adult cancer survivors with a primary malignancy (excluding central nervous system malignancies) who had completed three or more cycles of adjuvant chemotherapy in the previous 6 to 60 months and reported persistent cognitive symptoms. All participants received a 30-minute telephone consultation and were then randomly assigned to the 15-week, home-based intervention or to standard care. Primary outcome was self-reported cognitive function (Functional Assessment of Cancer Therapy Cognitive Function [FACT-COG] perceived cognitive impairment [PCI] subscale): difference between groups after intervention (T2) and 6 months later (T3). Results A total of 242 participants were randomly assigned: median age, 53 years; 95% female. The primary outcome of difference in FACT-COG PCI was significant, with less PCI in the intervention group at T2 (P<.001). This difference was sustained at T3 (P<.001). At T2, there was a significant difference in all FACT-COG subscales, favoring the intervention. Neuropsychological results were not significantly different between the groups at T2 or T3. There were significantly lower levels of anxiety/depression and fatigue in the intervention group at T2. There were significant improvements in stress in the intervention group at both time points. There was no significant difference in quality of life between the groups at T2, but the intervention group had better quality of life at T3. Conclusion The intervention, Insight, led to improvements in cognitive symptoms compared with standard care. To our knowledge, this is the first large randomized controlled trial showing an improvement in selfreported cognitive function in cancer survivors, indicating that this intervention is a feasible treatment.

AB - Purpose Cognitive impairment is reported frequently by cancer survivors. There are no proven treatments. We evaluated a cognitive rehabilitation program (Insight) and compared it with standard care in cancer survivors self-reporting cognitive symptoms. Patients and Methods We recruited adult cancer survivors with a primary malignancy (excluding central nervous system malignancies) who had completed three or more cycles of adjuvant chemotherapy in the previous 6 to 60 months and reported persistent cognitive symptoms. All participants received a 30-minute telephone consultation and were then randomly assigned to the 15-week, home-based intervention or to standard care. Primary outcome was self-reported cognitive function (Functional Assessment of Cancer Therapy Cognitive Function [FACT-COG] perceived cognitive impairment [PCI] subscale): difference between groups after intervention (T2) and 6 months later (T3). Results A total of 242 participants were randomly assigned: median age, 53 years; 95% female. The primary outcome of difference in FACT-COG PCI was significant, with less PCI in the intervention group at T2 (P<.001). This difference was sustained at T3 (P<.001). At T2, there was a significant difference in all FACT-COG subscales, favoring the intervention. Neuropsychological results were not significantly different between the groups at T2 or T3. There were significantly lower levels of anxiety/depression and fatigue in the intervention group at T2. There were significant improvements in stress in the intervention group at both time points. There was no significant difference in quality of life between the groups at T2, but the intervention group had better quality of life at T3. Conclusion The intervention, Insight, led to improvements in cognitive symptoms compared with standard care. To our knowledge, this is the first large randomized controlled trial showing an improvement in selfreported cognitive function in cancer survivors, indicating that this intervention is a feasible treatment.

UR - http://www.scopus.com/inward/record.url?scp=85009913059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009913059&partnerID=8YFLogxK

U2 - 10.1200/JCO.2016.67.8201

DO - 10.1200/JCO.2016.67.8201

M3 - Article

C2 - 28056205

AN - SCOPUS:85009913059

VL - 35

SP - 217

EP - 225

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 2

ER -